Dr. Tad Bradley Marshall, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3694 Highland Ave Ste 26, Highland, CA 92346 Phone: 909-425-9000 Fax: 909-425-9111 |
Dr. Loren Cecil Marshall, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3694 Highland Ave, #26, Highland, CA 92346 Phone: 909-425-9000 |
Dr. Roland Robert Rodriguez, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 7223 Church St, Suite A10, Highland, CA 92346 Phone: 909-856-0213 |
Dr. Billy Ray Lyon, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 7231 Palm Ave, Highland, CA 92346 Phone: 909-862-8888 Fax: 909-864-5951 |
Dr. Timothy Michael Stein, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 7245 Boulder Ave, Highland, CA 92346 Phone: 909-862-2331 Fax: 909-862-2811 |
Dr. Roger Paul Scott, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 27141 Baseline St Ste 5, Highland, CA 92346 Phone: 909-425-0148 Fax: 909-425-0174 |
News Archive
Siddhartha Sikdar, Professor, Bioengineering, Volgenau School of Engineering, Parag Chitnis, Assistant Professor, Bioengineering, and Guoqing Diao, Associate Professor, Statistics, are working to develop and evaluate a prototype prosthetic control system that uses wearable ultrasound imaging sensors to sense residual muscle activity rather than electromyography.
Reginald C. Farrow and Zafer Iqbal, research professors at NJIT, were awarded a patent today for an improved method of fabricating arrays of nanoscale electrical probes. Their discovery may lead to improved diagnostic tools for measuring the spatial variation of electrical activity inside biological cells.
Children with differences of sex development (DSD) are born with reproductive organs that are not typically male or female. They may face infertility from abnormal development of testes or ovaries, and in some patients these organs are surgically removed to prevent an increased risk of germ cell cancer.
Biogen Idec Inc. (NASDAQ:BIIB) announced today that FBC Acquisition Corp., its wholly owned subsidiary, has commenced a tender offer to acquire all of the outstanding shares of Facet Biotech Corporation (NASDAQ:FACT) for $14.50 per share in cash, in furtherance of its previously announced acquisition proposal. The tender offer is scheduled to expire at 12:00 midnight, ET, on October 19, 2009, unless extended or terminated.
Researchers at the University of Michigan Medical Center have, for the first time, identified human pancreatic cancer stem cells. Their work indicates that these cells are likely responsible for the aggressive tumor growth, progression, and metastasis that define this deadly cancer.
› Verified 3 days ago